Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Global Companion Animal Specialty Drugs Market Growth Analysis in Pharmaceuticals Industry | Discover Company Insights in Technavio | ||
| By: PR Newswire Association LLC. - 23 Jul 2021 | Back to overview list |
|
|
NEW YORK, July 22, 2021 /PRNewswire/ -- Technavio's latest report on the companion animal specialty drugs market projects a growth of USD 2.80 billion, registering a CAGR of 5.20% during 2021-2025. According to the report, the Pharmaceuticals sector will have a POSITIVE impact owing to the continued spread of the COVID-19 pandemic. Besides, the report provides a detailed analysis of the pre-and post-impact of COVID-19 on businesses.
Download a Sample Report Covering COVID-19 Impact The companion animal specialty drugs market share growth by the vaccines segment has been significant. The US is a key market for companion animal specialty drugs in North America. 39% of the market's growth will originate from North America during the forecast period. North America has been recording significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The rising awareness about disease prevention and pet insurance will facilitate the companion animal specialty drugs market growth in North America over the forecast period. Companion Animal Speciality Drugs Market: Major Growth Drivers The following factors are expected to drive the growth of the market during the forecast period:
Also, the ongoing trend of enhanced product offerings is expected to have a positive impact on the growth of the companion animal specialty drugs market during 2021-2025. Gain more insights into the global trends impacting the future of companion animal specialty drugs market. Request a Free Sample Report Now! Companion Animal Speciality Drugs Market: Key Vendor Offerings Bayer AG Bayer AG operates its business under segments- Pharmaceuticals, Crop science, and Consumer health. The company offers Veterinary Medicines. Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH operates its business under segments- Human Pharmaceuticals, Animal Health, Biopharmaceuticals, and Other. The company offers products for animal health. Ceva Sante Animale Ceva Sante Animale operates its business under segments- Companion animals, Cattle, Poultry, Small Ruminants, and Swine. The company offers companion animal specialty drugs. Reasons to Buy Companion Animal Specialty Drugs Market Report:
This report can be personalized according to your business needs. Related Reports on Information Technology Include: Animal Health Market in North America: Technavio's market research analyst predicts the global animal health market to grow at a CAGR of 4% during the forecast period. Global Animal Antimicrobials and Antibiotics Market: Technavio's analysts forecast the global animal antimicrobials and antibiotics market to grow at a CAGR of 5.25% over the forecast period. About Us Contact
SOURCE Technavio 
|
||
|
|
||
 | Back to overview list | |
View original content to download multimedia: